Viewing Study NCT01650805


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-01-15 @ 2:13 AM
Study NCT ID: NCT01650805
Status: TERMINATED
Last Update Posted: 2014-11-17
First Post: 2012-07-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
Sponsor:
Organization: